Effective Migraine Prevention with Convenient Daily Treatment
At Dears Pharmacy, we are pleased to offer a specialist Migraine Prevention consultation service for suitable patients using Atogepant (AQUIPTA®) 60 mg tablets.
AQUIPTA® is a once-daily prescription medicine used for the prevention of migraine in adults experiencing frequent migraine attacks. It works by blocking the CGRP receptor pathway, which plays a key role in migraine development.
What is AQUIPTA®?
AQUIPTA® (Atogepant) is a modern migraine prevention treatment designed to help reduce:
- Frequency of migraine attacks
- Severity of migraine symptoms
- Number of migraine days per month
- Impact migraines have on daily life, work and wellbeing.
Treatment is taken as:
- One 60 mg tablet once daily
- Can be taken with or without food
- Long-term preventative therapy under ongoing clinical review.
Who may benefit?
This service may be suitable for adults who:
- Experience frequent migraines
- Have migraines affecting work, family or quality of life
- Have not responded adequately to other preventative treatments
- Cannot tolerate traditional migraine prevention medicines
- Are seeking a modern targeted migraine prevention option
- A clinical assessment is required to determine suitability.
Our Migraine Prevention Consultation Includes
Comprehensive Clinical Assessment
Our pharmacist prescriber will assess:
- Migraine history and frequency
- Previous migraine treatments
- Current medications
- Medical history and contraindications
- Suitability for Atogepant therapy.
Treatment planning
Where clinically appropriate, we will:
- Supply AQUIPTA® 60 mg tablets
- Provide counselling on use and expectations
- Discuss side effects and monitoring
- Develop an ongoing migraine management plan.
Follow-up and monitoring
Patients may receive:
- Follow-up reviews
- Migraine diary guidance
- Ongoing treatment optimisation
- Safety and effectiveness monitoring.
Potential Benefits of AQUIPTA®
Clinical studies have shown AQUIPTA® may help reduce monthly migraine days and improve quality of life for many patients living with migraine.
Benefits may include:
- Fewer migraine attacks
- Reduced reliance on acute migraine medication
- Improved productivity and daily functioning
- Convenient once-daily dosing
Individual results may vary.
Possible Side Effects
- Nausea
- Constipation
- Fatigue
- Reduced appetite
Our clinical team will discuss all risks, precautions and monitoring requirements during your consultation.
Important information
AQUIPTA® is a prescription-only medicine and is only supplied following a clinical consultation where deemed appropriate by an independent prescriber.
This service is intended for migraine prevention and is not suitable for the treatment of acute migraine attacks.
Patients should seek urgent medical attention for new neurological symptoms, sudden severe headaches, or symptoms suggestive of stroke or other serious conditions.
Useful resources:
